Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis
ConclusionsTSH fall ≥ 80% may be an early marker of IH. Serial TSH measurement during ipilimumab therapy may be an inexpensive tool to expedite IH diagnosis.
Source: Pituitary - Category: Endocrinology Source Type: research
More News: Australia Health | Endocrinology | Hormones | Melanoma | Skin Cancer | Study | Thyroid | Yervoy